© 1994 British Society for Rheumatology
research-article |
CORRELATION OF BLOOD LEVELS OF SOLUBLE VASCULAR CELL ADHESION MOLECULE-1 WITH DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND VASCULITIS
*Department of Rheumatology, University of Birmingham Birmingham
British Biotechnology PLC Cowley, Oxford
Levels of soluble adhesion molecules have been shown to reflect their cell surface expression in vitro, and thus may provide a useful surrogate marker of surface expression at inflammatory sites. In patients with SLE and vasculitis, serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-Selectin were determined by ELISA during different stages of disease activity. Levels of soluble(s) VCAM-1 correlated with disease activity in patients with SLE, being significantly higher during active compared with inactive disease (P = 0.003), and normalizing with clinical remission. By contrast, in patients with vasculitis, although sVCAM-1 levels were elevated in active disease, they fell but did not normalize in inactive disease, suggesting that treatment may be suppressing the clinical manifestations rather than targeting the underlying pathogenic mechanism. Soluble ICAM-1 and E-Selectin levels did not reflect disease activity in either SLE or vasculitis.
KEY WORDS: Soluble adhesion molecules, Systemic lupus erythematosus, Vasculitis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E Robak, M Kierstan, B Cebula, A Krawczynska, A Sysa-Jedrzejowska, A Wierzbowska, P Smolewski, and T Robak Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus Lupus, April 1, 2009; 18(4): 332 - 341. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R. Batuca, P. R. J. Ames, M. Amaral, C. Favas, D. A. Isenberg, and J. Delgado Alves Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus Rheumatology, January 1, 2009; 48(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. N. Bruce 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology, December 1, 2005; 44(12): 1492 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M J Lewis and D D'Cruz Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus Lupus, March 1, 2005; 14(3_suppl): s17 - s26. [Abstract] [PDF]
|
|
|
|
|
|
M. Lewis and D. D'Cruz Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus Lupus, January 1, 2005; 14(1_suppl): s17 - s26. [Abstract] [PDF]
|
|
|
|
|
|
C. Y. Ho, C. K. Wong, E. K. Li, L. S. Tam, and C. W. K. Lam Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus Rheumatology, January 1, 2003; 42(1): 117 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A Klimiuk, S Sierakowski, R Latosiewicz, J P Cylwik, B Cylwik, J Skowronski, and J Chwiecko Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis Ann Rheum Dis, September 1, 2002; 61(9): 804 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cogalgil and S. Taysi Levels of Antioxidant Proteins and Soluble Intercellular Adhesion Molecule-1 in Serum of Patients with Rheumatoid Arthritis Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 264 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Reiss, N. W. Awadallah, S. Malhotra, M. C. Montesinos, E. S. L. Chan, N. B. Javitt, and B. N. Cronstein Immune complexes and IFN-{gamma} decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages J. Lipid Res., November 1, 2001; 42(11): 1913 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Huhtinen, M. Puolakkainen, K. Laasila, M. Sarvas, A. Karma, and M. Leirisalo-Repo Chlamydial Antibodies in Patients with Previous Acute Anterior Uveitis Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1816 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kagawa, S. Nomura, M. Nagahama, Y. Ozaki, and S. Fukuhara Effect of Bezafibrate on Soluble Adhesion Molecules and Platelet Activation Markers in Patients With Connective Tissue Diseases and Secondary Hyperlipidemia Clinical and Applied Thrombosis/Hemostasis, April 1, 2001; 7(2): 153 - 157. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Ara, E. Mirapeix, P. Arrizabalaga, R. Rodriguez, C. Ascaso, R. Abellana, J. Font, and A. Darnell Circulating soluble adhesion molecules in ANCA-associated vasculitis Nephrol. Dial. Transplant., February 1, 2001; 16(2): 276 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kurozawa and Y. Nasu Circulating Adhesion Molecules in Patients with Vibration-Induced White Finger Angiology, December 1, 2000; 51(12): 1003 - 1006. [PDF]
|
|
|
|
|
|
P. Toivanen and A. Toivanen Two forms of reactive arthritis? Ann Rheum Dis, December 1, 1999; 58(12): 737 - 741. [Abstract] [Full Text]
|
|
|
|
|
|
Y Ikeda, T Fujimoto, M Ameno, H Shiiki, and K Dohi Relationship between lupus nephritis activity and the serum level of soluble VCAM-1 Lupus, June 1, 1998; 7(5): 347 - 354. [Abstract] [PDF]
|
|